These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11341999)

  • 1. Inhibitors of advanced glycation end product-associated protein cross-linking.
    Lehman TD; Ortwerth BJ
    Biochim Biophys Acta; 2001 Feb; 1535(2):110-9. PubMed ID: 11341999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic approach to evaluate the modification of lens proteins by glycation-induced crosslinking.
    Lee KW; Simpson G; Ortwerth B
    Biochim Biophys Acta; 1999 Jan; 1453(1):141-51. PubMed ID: 9989254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
    Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of glycation crosslinking by the sugar-dependent incorporation of [14C]lysine into protein.
    Prabhakaram M; Ortwerth BJ
    Anal Biochem; 1994 Feb; 216(2):305-12. PubMed ID: 8179185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
    Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
    Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts.
    Al-Abed Y; Bucala R
    Bioconjug Chem; 2000; 11(1):39-45. PubMed ID: 10639083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro. off.
    Lee KW; Mossine V; Ortwerth BJ
    Exp Eye Res; 1998 Jul; 67(1):95-104. PubMed ID: 9702182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphates in vitro.
    Swamy MS; Tsai C; Abraham A; Abraham EC
    Exp Eye Res; 1993 Feb; 56(2):177-85. PubMed ID: 8462651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid glycation: the reactions of L-threose in lens tissue.
    Ortwerth BJ; Speaker JA; Prabhakaram M; Lopez MG; Li EY; Feather MS
    Exp Eye Res; 1994 Jun; 58(6):665-74. PubMed ID: 7925706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favored and disfavored pathways of protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus glucosepane.
    Nemet I; Strauch CM; Monnier VM
    Amino Acids; 2011 Jan; 40(1):167-81. PubMed ID: 20607325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
    Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
    Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.
    Frye EB; Degenhardt TP; Thorpe SR; Baynes JW
    J Biol Chem; 1998 Jul; 273(30):18714-9. PubMed ID: 9668043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycation and cross-linking of isolated lens crystallins by ascorbic acid.
    Prabhakaram M; Ortwerth BJ
    Exp Eye Res; 1992 Sep; 55(3):451-9. PubMed ID: 1426076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
    Booth AA; Khalifah RG; Todd P; Hudson BG
    J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products induce crosslinking of collagen in vitro.
    Sajithlal GB; Chithra P; Chandrakasan G
    Biochim Biophys Acta; 1998 Sep; 1407(3):215-24. PubMed ID: 9748585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo glycation of bovine lens crystallins.
    Van Boekel MA; Hoenders HJ
    Biochim Biophys Acta; 1992 Sep; 1159(1):99-102. PubMed ID: 1390916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking.
    Hudson DM; Archer M; King KB; Eyre DR
    J Biol Chem; 2018 Oct; 293(40):15620-15627. PubMed ID: 30143533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking.
    Kim J; Jeong IH; Kim CS; Lee YM; Kim JM; Kim JS
    Arch Pharm Res; 2011 Mar; 34(3):495-500. PubMed ID: 21547683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.
    Tessier F; Obrenovich M; Monnier VM
    J Biol Chem; 1999 Jul; 274(30):20796-804. PubMed ID: 10409619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of glucose, galactose and pyridoxal phosphate to lens crystallins.
    Ganea E; Rixon KC; Harding JJ
    Biochim Biophys Acta; 1994 Jul; 1226(3):286-90. PubMed ID: 8054360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.